PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Sloka PR

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Exports & Patents Awards Presented During Pharmexcil’s Pharma CEO’s Conclave - The Outstanding Export Performance Awards and Patents Awards 2009-10 were presented during the Pharma CEO’s Conclave in the city on Friday. The event was organized by Pharmaceuticals Export Promotion Council (Pharmexcil)
Exports & Patents Awards Presented During Pharmexcil’s Pharma CEO’s Conclave

 

NewswireToday - /newswire/ - Hyderabad, Andhra Pradesh, India, 2010/09/24 - The Outstanding Export Performance Awards and Patents Awards 2009-10 were presented during the Pharma CEO’s Conclave in the city on Friday. The event was organized by Pharmaceuticals Export Promotion Council (Pharmexcil).

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The Chief Minister, Mr. K Rosaiah who was the chief guest presented the Outstanding Export Performance Awards 2009-10. In all, 12 awards were presented for export performance. While Ranbaxy Laboratories Limited bagged the Outstanding Exports Award (Overall category), Cadila Healthcare was awarded Outstanding Exports Award (Overall Emerging Category). Aurobindo Pharma Limited bagged the Outstanding Exports Award Formulations (Overall category) and Matrix Laboratories Limited won the Outstanding Exports Award Formulations (Emerging category).

Some of the companies that bagged the Patents Awards 2009-10, presented to companies who secured patents in 2009-10, included Suven Life Sciences (Gold awardee for Drug Discovery product category), Glenmark Pharmaceuticals Limited (Silver awardee for Drug Discovery category) and Matrix Laboratories Limited (Certification of Appreciation in API / Bulk drugs product category).

Speaking on the occasion, the Chief Minister Mr. K Rosaiah said, “I am very happy to place on record that, after establishment of Pharmexcil, the exports of our country have grown from about USD 3.8 billion to USD 8.9 billion. Exports have grown with formulations at 58%, bulk drugs at 41% and herbals at 1%.” The state government had supported establishment of Pharmexcil in Hyderabad through seed capital assistance. “I compliment Pharmexcil for conducting this event on a grand scale. I wish the deliberations in this conclave will go a long way to excel the growth of Indian Pharma sector,” he added.

“The Indian market will grow from USD 8.4 billion in 2007 to USD 21.5 billion in 2015. A significant point to note is that 8% of the market in 2015 will be from sales of patented drugs, which is a clear result of the respect for patents in India. We are amidst an ecosystem that fosters a culture for innovation,” said Mr. Smitesh Shah, chairman, Pharmexcil.

Earlier, Mr. Stefan Borgas, CEO, Lonza AG (Switzerland) delivered the key note speech on “Global Paradigm Shift in Pharma”. Mr. Rajeev Kher, joint secretary, department of commerce, Govt. of India, Dr. S M Jharwal, chairman, National Pharmaceutical Pricing Authority, Mr. B P Acharya, principal secretary, industries department, Govt. of AP, Mr. R P Meena, director general, drugs and copy rights, Govt. of AP and Dr. P V Appaji, executive director, Pharmexcil were present on the occasion.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Sloka PR

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Exports & Patents Awards Presented During Pharmexcil’s Pharma CEO’s Conclave

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Press Office - SlokaPR.com 
+91 40 32444663 info[.]slokapr.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sloka PR securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Sloka PR / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow Ltd

Visit  SKS Media | SKS Associates Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)